Expert Opinion on the Proper Use of Teduglutide as Treatment for Short Bowel Syndrome in Adult Patients
Not Applicable
Recruiting
- Conditions
- short bowel syndrome
- Registration Number
- JPRN-UMIN000052594
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Not applicable
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method An expert opinion on appropriate treatment of adult SBS with TED
- Secondary Outcome Measures
Name Time Method